Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy

Fig. 2

Expression of NK cell ligands on mock- vs. MeV-GFP-infected A673 sarcoma cells. A673 cells were mock-infected (left panels) or infected with MeV-GFP at MOI 0.5 (right panels). At 48 hpi expression levels of NK cell ligands MICA/MICB (a), ULBP1 (b), ULBP2 (c), ULBP3 (d), CD112 (e), and CD155 (f) were determined by flow cytometry. One representative of three independent experiments is shown. MeV, measles vaccine virus; GFP, green fluorescent protein

Back to article page